We are live on ! Find out more
AP

Antipodes Partners Portfolio holdings

AUM $5.46B
1-Year Est. Return 26.64%
This Fund
S&P 500
This Quarter Est. Return
+5.97%
1 Year Est. Return
+26.64%
3 Year Est. Return
+96.4%
5 Year Est. Return
+160.76%
10 Year Est. Return
AUM
$4.76B
AUM Growth
+$305M
Cap. Flow
+$53.3M
Cap. Flow %
1.12%
Top 10 Hldgs %
37.47%
Holding
149
New
33
Increased
46
Reduced
42
Closed
19

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$120M
2
TTE icon
TotalEnergies
TTE
+$87.9M
3
AMZN icon
Amazon
AMZN
+$68.8M
4
MSFT icon
Microsoft
MSFT
+$58.4M
5
ORCL icon
Oracle
ORCL
+$57.1M

Sector Composition

Rank Sector Weight
1 Utilities 25.97%
2 Technology 13.9%
3 Healthcare 12.33%
4 Financials 8.66%
5 Consumer Discretionary 8.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRKR icon
76
Bruker
BRKR
$8.58B
$620K 0.01%
13,150
+4,982
+61% +$211K
HON icon
77
CALL
Honeywell
HON
$77B
$604K 0.01%
+2,067
New +$404K
FRMI
78
Fermi Inc
FRMI
$3.75B
$465K 0.01%
+58,160
New +$1.13M
MGNI icon
79
Magnite
MGNI
$3.47B
$403K 0.01%
+24,831
New +$412K
MNDY icon
80
monday.com
MNDY
$3.75B
$351K 0.01%
2,381
+1,078
+83% +$182K
SG icon
81
Sweetgreen
SG
$648M
$351K 0.01%
+51,873
New +$357K
TDW icon
82
Tidewater
TDW
$4.46B
$277K 0.01%
5,485
+2,123
+63% +$112K
LINE
83
Lineage Inc
LINE
$9.42B
$236K ﹤0.01%
+6,729
New +$249K
JCI icon
84
Johnson Controls International
JCI
$91.2B
$209K ﹤0.01%
1,748
-718,892
-100% -$82.5M
SDGR icon
85
Schrodinger
SDGR
$1.4B
$205K ﹤0.01%
11,464
+6,552
+133% +$124K
CLPR
86
Clipper Realty
CLPR
$47.5M
$202K ﹤0.01%
+52,758
New +$197K
IMNM icon
87
Immunome
IMNM
$2.91B
$190K ﹤0.01%
8,834
-2,058
-19% -$36.1K
ARGX icon
88
argenx
ARGX
$54.2B
$165K ﹤0.01%
196
-91
-32% -$77.9K
SYK icon
89
Stryker
SYK
$133B
$101K ﹤0.01%
288
+197
+216% +$71.8K
AVA icon
90
Avista
AVA
$3.2B
$92K ﹤0.01%
+2,388
New +$93.3K
STE icon
91
Steris
STE
$23.3B
$89.2K ﹤0.01%
352
COR icon
92
Cencora
COR
$62B
$82.8K ﹤0.01%
245
-21
-8% -$7.16K
QGEN icon
93
Qiagen
QGEN
$9.04B
$77.5K ﹤0.01%
1,637
+111
+7% +$5.13K
TMO icon
94
Thermo Fisher Scientific
TMO
$222B
$75.9K ﹤0.01%
131
+33
+34% +$18.7K
NTRA icon
95
Natera
NTRA
$45.9B
$75.6K ﹤0.01%
330
REGN icon
96
Regeneron Pharmaceuticals
REGN
$83.2B
$74.9K ﹤0.01%
+97
New +$65.9K
ESTA icon
97
Establishment Labs
ESTA
$2.21B
$70.6K ﹤0.01%
969
-338
-26% -$20.4K
MDT icon
98
Medtronic
MDT
$114B
$70.1K ﹤0.01%
+730
New +$70.9K
GILD icon
99
Gilead Sciences
GILD
$165B
$68.4K ﹤0.01%
+557
New +$67.7K
MYRG icon
100
MYR Group
MYRG
$5.15B
$68K ﹤0.01%
311
+10
+3% +$2.18K

Similar funds

Antipodes Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Antipodes Partners held 149 positions worth $4.76B, up 6.8% from $4.46B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Antipodes Partners's Q4 2025 filing shows 33 new, 46 increased, 42 reduced and 19 closed positions. Its largest new stake was Meta Platforms (Facebook): 179,243 shares worth $118M. The largest sale was Alphabet (Google) Class A, an estimated $153M.

By sector, the portfolio is most concentrated in Utilities at 26% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.

  • Antipodes Partners's largest Q4 2025 buy was Meta Platforms (Facebook): 179,243 shares worth $118M.
  • Antipodes Partners added most to Amazon in Q4 2025, an estimated $68.8M increase.
  • Antipodes Partners's biggest Q4 2025 reduction was Advanced Micro Devices, cutting an estimated $90.6M.
  • Antipodes Partners fully exited Alphabet (Google) Class A in Q4 2025, selling an estimated $153M.
  • Antipodes Partners's ten largest holdings make up 37% of its $4.76B portfolio in Q4 2025.
  • Antipodes Partners opened 33 new positions and closed 19 in Q4 2025.
  • Antipodes Partners's portfolio value rose 6.8% quarter-over-quarter to $4.76B.

Based on Antipodes Partners's 13F filing for Q4 2025, filed 5 Feb 2026.